当前位置: 首页 > 期刊 > 《中国当代医药》 > 2018年第6期
编号:13240235
吉兰—巴雷综合征的研究进展(4)
http://www.100md.com 2018年2月25日 《中国当代医药》 2018年第6期
     [18]Raphael JC,Chevret S,Hughes RA,et al.Plasma exchange for Guillain-Barré syndrome[J].Cochrane Database Syst Rev,2012,(7):CD001798.

    [19]王偉芳,王玉忠,郝延磊.吉兰-巴雷综合症的免疫治疗进展[J].中国神经免疫学和神经病学杂志,2017,24(3):210-213.

    [20]Hughes RA,Newsom-David JM,Perkin GD,et al.Controlled trial prednisolone in acute poly- neuropathy[J].Lancet,1978, 2(8093):750-753.

    [21]Hughes RA,van Doorn PA.Corticosteroids for Guillain-Barré syndrome[J].Cochrane Database Syst Rev,2012,(8):CD001446.

    [22]Phongsisay V,Susuki K,Matsuno K,et al.Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barré syndrome[J].J Neuroim-munol,2008,205(1-2):101-104.

    [23]Halstead SK,Zitman FM,Humphreys PD,et al.Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model[J].Brain,2008,131(Pt 5):1197-1208.

    [24]Zhang G,Lehmann HC,Bogdanova N,et al.Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy[J].PLoS One,2011,6(10):e27067.

    [25]Hughes RA,Swan AV,Raphal JC,et al.Immunotherapy for Guillain-Barré syndrome:a systematic review[J].Brain,2007,130(Pt 9):2245-2257.

    [26]何姿蓉,彭洪莲,郭鸿,等.针灸治疗格林-巴利综合征的研究进展[J].药物与人,2014,27(12):40-41.

    (收稿日期:2017-11-01 本文编辑:许俊琴), 百拇医药(崔国静 李勤)
上一页1 2 3 4